30594554 30286326 27698810 30917007 25388166 28692379 25642418 32606964 30871013 30637412 33038264 26950691 26234767 24025252 25152373 26271487 25634657 35454859 30658075 29579541 - Search Results

Year	Number of Results
2013	1
2014	3
2015	5
2016	2
2017	1
2018	4
2019	5
2020	2
2021	1
2022	1

1

Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism.

Dunn J, Ferluga S, Sharma V, Futschik M, Hilton DA, Adams CL, Lasonder E, Hanemann CO. Dunn J, et al. EBioMedicine. 2019 Feb;40:77-91. doi: 10.1016/j.ebiom.2018.12.048. Epub 2018 Dec 26. EBioMedicine. 2019. PMID: 30594554 Free PMC article.

2

Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.

Williams AP, Garner EF, Waters AM, Stafman LL, Aye JM, Markert H, Stewart JE, Beierle EA. Williams AP, et al. Transl Oncol. 2019 Jan;12(1):84-95. doi: 10.1016/j.tranon.2018.09.011. Epub 2018 Oct 1. Transl Oncol. 2019. PMID: 30286326 Free PMC article.

3

Association between SET expression and glioblastoma cell apoptosis and proliferation.

He K, Shi L, Jiang T, Li Q, Chen Y, Meng C. He K, et al. Oncol Lett. 2016 Oct;12(4):2435-2444. doi: 10.3892/ol.2016.4951. Epub 2016 Aug 3. Oncol Lett. 2016. PMID: 27698810 Free PMC article.

4

The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction.

De Palma RM, Parnham SR, Li Y, Oaks JJ, Peterson YK, Szulc ZM, Roth BM, Xing Y, Ogretmen B. De Palma RM, et al. FASEB J. 2019 Jun;33(6):7647-7666. doi: 10.1096/fj.201802264R. Epub 2019 Mar 27. FASEB J. 2019. PMID: 30917007 Free PMC article.

5

Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer.

Cristóbal I, Rincón R, Manso R, Caramés C, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Cristóbal I, et al. Clin Cancer Res. 2015 Jan 15;21(2):347-56. doi: 10.1158/1078-0432.CCR-14-0724. Epub 2014 Nov 11. Clin Cancer Res. 2015. PMID: 25388166

6

Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth.

Mukhopadhyay A, Hanold LE, Thayele Purayil H, Gisemba SA, Senadheera SN, Aldrich JV. Mukhopadhyay A, et al. Cancer Biol Ther. 2017 Aug 3;18(8):571-583. doi: 10.1080/15384047.2017.1345384. Epub 2017 Jul 10. Cancer Biol Ther. 2017. PMID: 28692379 Free PMC article.

7

Regulation of PP2A by Sphingolipid Metabolism and Signaling.

Oaks J, Ogretmen B. Oaks J, et al. Front Oncol. 2015 Jan 15;4:388. doi: 10.3389/fonc.2014.00388. eCollection 2014. Front Oncol. 2015. PMID: 25642418 Free PMC article. Review.

8

Upregulated SET Promotes Cell Survival Through Activating Akt/NF-κB Signal in Colorectal Carcinoma.

Zhu J, Shi L, Du G, Li L, Liu M. Zhu J, et al. Cancer Manag Res. 2020 Jun 19;12:4735-4745. doi: 10.2147/CMAR.S255930. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606964 Free PMC article.

9

Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer.

Cristóbal I, Torrejón B, Rubio J, Santos A, Pedregal M, Caramés C, Zazo S, Luque M, Sanz-Alvarez M, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Cristóbal I, et al. J Clin Med. 2019 Mar 12;8(3):346. doi: 10.3390/jcm8030346. J Clin Med. 2019. PMID: 30871013 Free PMC article.

10

Epigenetics and Sphingolipid Metabolism in Health and Disease.

Wang W, Toran PT, Sabol R, Brown TJ, Barth BM. Wang W, et al. Int J Biopharm Sci. 2018 Oct;1(2):105. doi: 10.31021/ijbs.20181105. Epub 2018 Jan 22. Int J Biopharm Sci. 2018. PMID: 30637412 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results